Abstract |
Activated macrophages mediate inflammation, as they release nitric oxide and pro-inflammatory cytokines in various inflammatory diseases. Suppressing macrophage activation may alleviate inflammatory processes. Here, we report that (E)-3-(3,4-dihydroxy-2-methoxyphenyl)-1-(2,4-dihydroxyphenyl)prop-2-en-1-one (DDP), a novel licochalcone B derivative compound, inhibits inflammatory reactions in macrophages and protects mice from endotoxin shock. In vitro experiments showed that DDP suppressed the generation of nitric oxide and pro-inflammatory cytokines by suppressing the activation of nuclear factor-κB and activator protein-1 and simultaneously inhibited its upstream inflammatory signaling cascades in lipopolysaccharide in RAW264.7 cells. In an animal model, DDP protected BALB/c mice from lipopolysaccharide-induced endotoxin shock, possibly through inhibition of the production of inflammatory cytokines. DDP inhibited the production of inflammatory mediators and may be a potential target for treatment of various inflammatory diseases.
|
Authors | Ju-Hyung Park, Jong-Gab Jun, Jin-Kyung Kim |
Journal | Chemico-biological interactions
(Chem Biol Interact)
Vol. 224
Pg. 142-8
(Dec 05 2014)
ISSN: 1872-7786 [Electronic] Ireland |
PMID | 25451593
(Publication Type: Journal Article)
|
Copyright | Copyright © 2014 Elsevier Ireland Ltd. All rights reserved. |
Chemical References |
- 3-(3,4-dihydroxy-2-methoxyphenyl)-1-(2,4-dihydroxyphenyl)prop-2-en-1-one
- Anti-Inflammatory Agents, Non-Steroidal
- Chalcones
- Interleukin-1beta
- Interleukin-6
- Lipopolysaccharides
- NF-kappa B
- Nitrites
- Protein Kinase Inhibitors
- Tumor Necrosis Factor-alpha
- interleukin-6, mouse
- lipopolysaccharide, Escherichia coli O111 B4
- Nitric Oxide
- JNK Mitogen-Activated Protein Kinases
- Mitogen-Activated Protein Kinase 14
- licochalcone B
|
Topics |
- Animals
- Anti-Inflammatory Agents, Non-Steroidal
(pharmacology, therapeutic use)
- Cell Line
- Chalcones
(chemistry, pharmacology, therapeutic use)
- Interleukin-1beta
(antagonists & inhibitors)
- Interleukin-6
(antagonists & inhibitors)
- JNK Mitogen-Activated Protein Kinases
(antagonists & inhibitors)
- Lipopolysaccharides
(pharmacology)
- Mice
- Mitogen-Activated Protein Kinase 14
(antagonists & inhibitors)
- NF-kappa B
(antagonists & inhibitors, genetics)
- Nitric Oxide
(antagonists & inhibitors)
- Nitrites
(analysis, metabolism)
- Protein Kinase Inhibitors
(pharmacology)
- Shock, Septic
(drug therapy, metabolism)
- Stereoisomerism
- Tumor Necrosis Factor-alpha
(antagonists & inhibitors)
|